StonvexLoading…
StonvexStonvexStonvexCore line items from MSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-29 | Q1 2026 2026-02-28 | Q4 2025 2025-11-29 | Annual 2025 2025-08-30 | Q2 2025 2025-05-31 |
|---|---|---|---|---|---|
Revenue | $1.04B | $1.88B | $965.68M | $3.77B | $2.79B |
Operating Income | Not available | $141.03M | $76.24M | $301.56M | $217.26M |
Net Income | Not available | $94.29M | $51.80M | $199.33M | $142.78M |
EPS (Diluted) | $1.27 | $1.69 | $0.93 | $3.57 | $2.55 |
Total Assets | Not available | $2.45B | $2.49B | $2.46B | $2.48B |
Total Liabilities | Not available | $1.07B | $1.10B | $1.07B | $1.10B |
Cash & Equivalents | Not available | $46.19M | $40.25M | $56.23M | $71.69M |
Free Cash Flow OCF − CapEx | Not available | $80.48M | $7.41M | $240.88M | $182.35M |
Shares Outstanding | Not available | 55.94M | 55.98M | 55.89M | 55.90M |